CFD
HQL

Creative Financial Designs’s abrdn Life Sciences Investors HQL Stock Holding History

Creative Financial Designs’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.7K Hold
2,811
– – ﹤0.01% 925
2025
Q4 		$47.2K Hold
2,811
– – ﹤0.01% 886
2025
Q3 		$43.6K Hold
2,811
– – ﹤0.01% 897
2025
Q2 		$36K Hold
2,811
– – ﹤0.01% 974
2025
Q1 		$35.7K Hold
2,811
– – ﹤0.01% 939
2024
Q4 		$36.9K Hold
2,811
– – ﹤0.01% 892
2024
Q3 		$42.4K Hold
2,811
– – ﹤0.01% 825
2024
Q2 		$39.8K Hold
2,811
– – ﹤0.01% 805
2024
Q1 		$38.3K Hold
2,811
– – ﹤0.01% 795
2023
Q4 		$37.8K Buy
2,811
+611
+28% +$7.52K ﹤0.01% 747
2023
Q3 		$27.4K Hold
2,200
– – ﹤0.01% 781
2023
Q2 		$29.8K Hold
2,200
– – ﹤0.01% 762
2023
Q1 		$30.6K Buy
+2,200
New +$31.4K ﹤0.01% 702

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Creative Financial Designs's HQL Position: Q1 2026 in Review

Creative Financial Designs held its abrdn Life Sciences Investors (HQL) position steady in Q1 2026 at 2,811 shares worth $45.7K. The position accounts for ﹤0.01% of the portfolio, ranked #925.

Creative Financial Designs first reported a position in HQL in Q1 2023 and has held it in 13 quarters since. The position peaked at $47.2K in Q4 2025. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • Creative Financial Designs held 2,811 shares of abrdn Life Sciences Investors worth $45.7K as of Q1 2026.
  • Creative Financial Designs left its abrdn Life Sciences Investors share count unchanged in Q1 2026.
  • abrdn Life Sciences Investors made up ﹤0.01% of Creative Financial Designs's portfolio in Q1 2026, its #925 holding.
  • Creative Financial Designs first reported a position in abrdn Life Sciences Investors in Q1 2023 and has held it in 13 quarters since.
  • Creative Financial Designs's abrdn Life Sciences Investors position peaked at $47.2K in Q4 2025.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.